New Drugs and the Inefficiency of the Patent System
BEAT THE PRESS: "Once an effective treatment for Hepatitis C has been developed, there
is little medical benefit in having a second or third effective
treatment. The resources to develop these alternatives to Sovaldi could
have been much better utilized researching treatments for diseases which
do not presently have a cure. However the incentives provided by the
massive patent rents being earned by Gilead Sciences (the patent holder
for Sovaldi) give a huge incentive to other companies to carry through
duplicative research. If anyone cared about efficiency in the health
care system this point would be widely publicized."
"So keep fightin' for freedom and justice, beloveds, but don't you forget to have fun doin' it. Lord, let your laughter ring forth. Be outrageous, ridicule the fraidy-cats, rejoice in all the oddities that freedom can produce. And when you get through kickin' ass and celebratin' the sheer joy of a good fight, be sure to tell those who come after how much fun it was." - Molly Ivins 1944-2007
THIS IS ME...
... I blog from BURLINGTON, VERMONT. I'm a hustler about civic engagement & social action and I'll make publicity against a world that degrades and shames whatever way I can. Joy!